✦ LIBER ✦

A Clinical Study Of 22.5 mg. La-2550: A New Subcutaneous Depot Delivery System For Leuprolide Acetate For The Treatment Of Prostate Cancer

✍ Scribed by Chu, Franklin M.; Jayson, Maury; Dineen, Martin K.; Perez, Ramon; Harkaway, Richard; Tyler, Robert C.

Book ID: 122842179
Publisher: Lippincott Williams and Wilkins
Year: 2002
Tongue: English
Weight: 161 KB
Volume: 168
Category: Article
ISSN: 0022-5347
DOI: 10.1016/S0022-5347(05)64625-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A 12-Month Clinical Study of LA-2585 (45

A 12-Month Clinical Study of LA-2585 (45.0 MG): A New 6-Month Subcutaneous Delivery System for Leuprolide Acetate for the Treatment of Prostate Cancer

✍ Crawford, E. David; Sartor, Oliver; Chu, Franklin; Perez, Ramon; Karlin, Gary; G 📂 Article 📅 2006 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 130 KB

An eight-month clinical study of LA-2575

An eight-month clinical study of LA-2575 30.0 mg: a new 4-month, subcutaneous delivery system for leuprolide acetate in the treatment of prostate cancer

✍ Oliver Sartor; Martin K Dineen; Ramon Perez-Marreno; Franklin M Chu; Graham J Ca 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 114 KB

A subcutaneous delivery system for the e

A subcutaneous delivery system for the extended release of leuprolide acetate for the treatment of prostate cancer

✍ Perez-Marrero, Ramon; Tyler, Robert C 📂 Article 📅 2004 🏛 Informa plc 🌐 English ⚖ 175 KB

POS-03.60: A comparative head on efficac

POS-03.60: A comparative head on efficacy study of 3 monthly goserelin 10.8 mg, 3 monthly leuprolide 11.25 mg with 3 montly leuprolide 22.5 mg preparations for treatment in patients with prostate cancer

✍ R. Sood; S. Kathuria 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 72 KB

UP.34: A Comparative Head-On Efficacy St

UP.34: A Comparative Head-On Efficacy Study of 3 Monthly Goserelin 10.8 Mg, 3 Monthly Leuprolide 11.25 Mg and 3 Monthly Leuprolide 22.5 Mg with 6 Monthly Leuprolide 45mg Preparations for Treatment in Patients with Prostate Cancer

✍ R. Sood; S. Kathuria; H. Ahmad; M. Ahir 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 95 KB

Effectiveness, pharmacokinetics, and saf

Effectiveness, pharmacokinetics, and safety of a new sustained-release leuprolide acetate 3.75-mg depot formulation for testosterone suppression in patients with prostate cancer: A phase III, open-label, international multicenter study

✍ Michael Marberger; Amir V Kaisary; Neal D. Shore; Gary S. Karlin; Claudio Savuls 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 168 KB